Pasithea Therapeutics Corp. Share Price
KTTAPasithea Therapeutics Corp. Stock Performance
Open $0.57 | Prev. Close $0.57 | Circuit Range N/A |
Day Range $0.57 - $0.57 | Year Range $0.29 - $2.06 | Volume 100 |
Average Traded $0.57 |
Pasithea Therapeutics Corp. Share Price Chart
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Pasithea Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
11-Jun-26 | $0.57 | $0.57 | +0.00% |
11-Jun-26 | $0.57 | $0.57 | -1.56% |
09-Jun-26 | $0.57 | $0.58 | +0.00% |
08-Jun-26 | $0.58 | $0.58 | -2.20% |
05-Jun-26 | $0.61 | $0.59 | -4.84% |
04-Jun-26 | $0.62 | $0.62 | -1.90% |
03-Jun-26 | $0.63 | $0.63 | -2.77% |
FAQs on Pasithea Therapeutics Corp. Share Price
Can I buy Pasithea Therapeutics Corp. shares in India?
What is the share price of Pasithea Therapeutics Corp.?
What is the 5 year returns of Pasithea Therapeutics Corp.?
What are the high & low stock price of Pasithea Therapeutics Corp. today?
What is the 52-week high and low of Pasithea Therapeutics Corp. stock?